HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 521227Generated: October 31, 2026
Trifluoroacetic acid → 1-[1-(Biphenyl-4-ylmethyl)-4-(cyanomethyl)piperidin-4-yl]-3-(phenylamino)-1H-pyrazole-4-carboxamide
https://huagongshe.com/reaction/521227
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Trifluoroacetic acid | HCID 6422 | — |
| Reactant | (1,1'-Biphenyl)-4-carboxaldehyde | HCID 76689 | — |
| Reactant | 4-[4-Carbamoyl-3-(phenylamino)-1H-pyrazol-1-yl]-4-(cyanomethyl)piperidinium trifluoroacetate | HCID 86729383 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | 1-[1-(Biphenyl-4-ylmethyl)-4-(cyanomethyl)piperidin-4-yl]-3-(phenylamino)-1H-pyrazole-4-carboxamide | HCID 86729394 | — |
Reaction Steps
Biphenyl-4-carbaldehyde (12 mg, 0.070 mmol) was treated with a solution of 4-[4-carbamoyl-3-(phenylamino)-1H-pyrazol-1-yl]-4-(cyanomethyl)piperidinium trifluoroacetate (Intermediate #38-2) (20 mg, 0.050 mmol) and TFA (0.020 mL, 0.23 mmol) in DMF (0.65 mL). The resulting solution was then treated with MP-(OAc)3BH (80 mg, 0.16 mmol). The resulting mixture was shaken at ambient temperature for 16 hours on an orbital shaker. The mixture was then filtered through a 0.45 micron fit and the fit was washed with DMSO (1.0 mL). The filtrate was then purified directly by reverse-phase preparative HPLC (using a gradient elution of 5-95% MeCN/water, with 0.1% v/v NH4OH modifier). Desired fractions were identified, combined, and concentrated in vacuo to afford the title compound, Example #21-1.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US09328099B2 |
|---|
| Source dataset | uspto-grants-2016_05 |
|---|
| ORD ID | ord-cc3b3be777c1421cbe5c052ed9161bef |
|---|
| Source note | uspto-grants-2016_05 |
|---|